Empiric Antibiotic Therapy and Mortality Among Medicare Pneumonia Inpatients in 10 Western States-Reference-Cited by-同舟云学术

Empiric Antibiotic Therapy and Mortality Among Medicare Pneumonia Inpatients in 10 Western States

Published:2001-05 Issue:5 Volume:119 Page:1420-1426
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Houck Peter M.,MacLehose Richard F.,Niederman Michael S.,Lowery Joseph K.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference31 articles.

1. Data compendium;Health Care Financing Administration,1999

2. National Center for Health Statistics. Health United States, 2000 with adolescent health chartbook. Hyattsville, MD: National Center for Health Statistics, 2000; 177

3. Predicting hospital-associated mortality for Medicare patients: a method for patients with stroke, pneumonia, acute myocardial infarction, and congestive heart failure;Daley;JAMA,1988

4. Prognosis of patients hospitalized with community-acquired pneumonia;Fine;Am J Med,1990

5. Prognosis and outcome of patients with community-acquired pneumonia: a meta-analysis;Fine;JAMA,1995

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia;Intensive Care Medicine;2023-04-04

2. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia;European Respiratory Journal;2023-04

3. Acute organ injury and long-term sequelae of severe pneumococcal infections;Pneumonia;2023-03-05

4. Azithromycin combination therapy for community-acquired pneumonia: propensity score analysis;Scientific Reports;2019-12

5. In vitro susceptibility test of Xiao’er Feire Kechuan Oral Solution to Mycoplasma pneumoniae;Medicine;2019-07